Physicians

Department / Division
Surgery / Urology

Address
DUMC 2812
Durham, NC 27710

Appointment Telephone
919-668-8108

Office Telephone
919-681-8760

Fax Telephone
919-668-7093

Training

• MD, Duke University School of Medicine, 2004

Residency

• Internship, General Surgery, Duke University Medical Center, 2004-2005
• General Surgery, Duke University Medical Center, 2005-2006
• Urologic Surgery, Duke University Medical Center, 2007-2009 (Chief Resident, 2009-2010)

Fellowship

• Urologic Surgery Research, Duke University Medical Center, 2006-2007
• SUO Urologic Oncology, Institute of Urologic Oncology, University of California–Los Angeles, 2010-2012

Clinical Interests
Kidney cancer (including all facets of care for both localized and advanced pathology: minimally invasive techniques, renal-preservation surgeries, and advanced vascular/caval reconstruction as needed); testicular cancer (including the advanced upper-retroperitoneal and vascular techniques required to address post-chemotherapy pathology); bladder cancer (including bladder-sparing protocols, creation of neobladders, and robotic/minimally invasive techniques); prostate cancer (including robotic prostatectomy and multimodal management of locally advanced pathology); penile cancer (including penile-sparing techniques); advanced genitourinary cancer surgery; diagnosis and treatment of rare/unusual genitourinary and retroperitoneal tumors

Industry Relationships and Collaborations (What's this?)

This faculty member has no reported relationships with industry.

Representative Publications
Klatte, T; Kroeger, N; Rampersaud, EN; Birkhäuser, FD; Logan, JE; Sonn, G; Riss, J; Rao, PN; Kabbinavar, FF; Belldegrun, AS; Pantuck, AJ. Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma. Cancer. 2012;118:5777-5782. (2012) Abstract

Kroeger, N; Klatte, T; Birkhäuser, FD; Rampersaud, EN; Seligson, DB; Zomorodian, N; Kabbinavar, FF; Belldegrun, AS; Pantuck, AJ. Smoking negatively impacts renal cell carcinoma overall and cancer-specific survival. Cancer. 2012;118:1795-1802. (2012) Abstract

Kroeger, N; Rampersaud, EN; Patard, JJ; Klatte, T; Birkhäuser, FD; Shariat, SF; Lang, H; Rioux-Leclerq, N; Remzi, M; Zomorodian, N; Kabbinavar, FF; Belldegrun, AS; Pantuck, AJ. Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation. Journal of Urology. 2012;187:418-423. (2012) Abstract

Kroeger, N; Seligson, DB; Klatte, T; Rampersaud, EN; Birkhäuser, FD; Rao, PN; Leppert, JT; Zomorodian, N; Kabbinavar, FF; Belldegrun, AS; Pantuck, AJ. Clinical, molecular, and genetic correlates of lymphatic spread in clear cell renal cell carcinoma. European Urology. 2012;61:888-895. (2012) Abstract

Rampersaud, EN; Belldegrun, AS. Words of Wisdom. Re: randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance. European Urology. 2011;59:301-302. (2011) Abstract

Rampersaud, EN; Vujaskovic, Z; Inman, BA. Hyperthermia as a treatment for bladder cancer. Oncology. 2010;24:1149-1155. (2010) Abstract

Rampersaud, EN; Sun, L; Moul, JW; Madden, J; Freedland, SJ. Percent tumor involvement and risk of biochemical progression after radical prostatectomy. Journal of Urology. 2008;180:571-576. (2008) Abstract